ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 736,62
1,33%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Fusion Pharmaceuticals Inc (FUSN)

  7. Fusion Pharmaceuticals Inc (FUSN) Actualités

FUSN Fusion Pharmaceuticals Inc

21,44
-0,05 (-0,23%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Fusion Pharmaceuticals Inc FUSN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -0,23% 21,44 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
21,50 21,43 21,51 21,45 21,49
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202419:56PRNUSKuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to..
25/4/202422:34PRNUSFusion Pharmaceuticals Mails Circular for Special Meeting of..
09/4/202422:05PRNCAFusion Pharmaceuticals Announces Presentation of Interim..
20/3/202421:10PRNUSKuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to..
20/3/202421:05PRNCAFusion Pharmaceuticals Reports Fourth Quarter and Full Year..
19/3/202408:00PRNUSFusion Pharmaceuticals to be Acquired by AstraZeneca,..
06/3/202413:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/3/202422:43PRNUSFusion Pharmaceuticals to Present Interim Data from the..
26/2/202413:45PRNCAFusion Pharmaceuticals to Present at Upcoming March Investor..
16/2/202422:05EDGAR2Form 8-K - Current report
16/2/202414:45PRNUSFusion Pharmaceuticals Enters into Exclusive Worldwide..
07/2/202413:45PRNUSFusion Pharmaceuticals to Present at the Oppenheimer 34th..
06/2/202422:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
19/1/202422:13EDGAR2Form 8-K - Current report
19/1/202422:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202414:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
05/1/202400:53DJNShares of Fusion Pharmaceuticals Rise 7.8% With Study..
04/1/202422:31EDGAR2Form 8-K - Current report
04/1/202422:05PRNUSFusion Pharmaceuticals Announces Clinical Program and..
16/11/202312:45BWBWXT Medical Expands Collaboration with Fusion..
08/11/202322:15PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
08/11/202314:15PRNCAFusion Pharmaceuticals to Present at Upcoming Investor..
07/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:45EDGAR2Form 8-K - Current report
07/11/202313:00PRNCAFusion Pharmaceuticals Announces Third Quarter 2023..
16/10/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202322:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/10/202322:30EDGAR2Form 8-K - Current report
16/10/202313:50PRNCAFusion Pharmaceuticals Appoints Life Science Industry..
12/10/202313:45PRNUSFusion Pharmaceuticals Announces Presentation of Preclinical..
06/9/202322:25PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/9/202322:10PRNCAFusion Pharmaceuticals to Present at Upcoming September..
09/8/202322:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
08/8/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:30EDGAR2Form 8-K - Current report
08/8/202313:00PRNUSFusion Pharmaceuticals Announces Second Quarter 2023..
06/7/202322:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
26/6/202314:05PRNCAFusion Pharmaceuticals to Present Interim Data from Phase 1..
16/6/202314:05PRNCAFusion Pharmaceuticals to Present at the TD Cowen..
07/6/202313:35PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
31/5/202322:10PRNUSFusion Pharmaceuticals to Present at the Jefferies..
11/5/202313:15PRNUSFusion Pharmaceuticals Announces First Quarter 2023..
09/5/202313:45PRNUSFusion Pharmaceuticals to Present at the Guggenheim..

Dernières Valeurs Consultées

NASDAQ
FUSN
Fusion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés